Home Pregnancy-associated plasma protein A: spotlight on kidney diseases
Article Publicly Available

Pregnancy-associated plasma protein A: spotlight on kidney diseases

  • Marta Kalousová

    Prof. Marta Kalousová, MD, PhD (1974) graduated from the First Faculty of Medicine, Charles University in Prague, Czech Republic in 1998 and since 2010 she has been Professor of Medical Chemistry and Biochemistry at the Institute of Medical Biochemistry and Laboratory Medicine of this Faculty. She is a specialist in clinical chemistry and internal medicine-nephrology. Her main areas of interest include testing of new biochemical and molecular genetic biomarkers and their clinical significance, especially markers related to cardiovascular risk in patients with chronic kidney diseases, pregnancy proteins, tumor markers and advanced glycation end-products and oxidative stress. She is the author of more then 100 scientific papers, students’ book Atlas of pathobiochemistry and two book chapters, and a member of the editorial board of Kidney and Blood Pressure Research. Prof. Kalousová received many awards for her scientific work, including L’Oréal Czech Republic for Women in Science and Jan Brod Prize.

    EMAIL logo
    , Vladimír Tesaíř

    Prof. Vladimír Tesař, MD, PhD, MBA, FASN, FERA, was born May 5, 1957 and graduated in 1982 from the 1st Faculty of Medicine, Charles University, Prague. He is Professor of Medicine (since 1999) and the Head of Department of Nephrology, 1st Faculty of Medicine, Charles University (since 2003). His main areas of interest are glomerular disease (ANCA-vasculitis, lupus nephritis, membranous and IgA nephropathy), cardiovascular complications of chronic kidney disease and hereditary diseases of the kidney. Prof. Tesař is an author and co-author of more than 260 peer reviewed publications in leading journals and one of the main authors of two monographies. He is a member of many scientific societies (e.g., Fellow of the American Society of Nephrology since 2005) and editorial boards (e.g., Folia Biologica, Kidney and Blood Pressure Research, Blood Purification).

    , Alexandra Muravská

    Alexandra Muravská, MSc was born December 23, 1983, in Vranov nad Toplou, Slovakia. She graduated in 2007 with a degree in Biochemistry from the Faculty of Science, Charles University in Prague. Currently, she is a PhD student of Biochemistry and Pathobiochemistry at the 1st Faculty of Medicine, Charles University in Prague. Her research work has concentrated on searching new biochemical and molecular genetic markers of pathological states in pregnancy and other diseases.

    and Tomáš Zima

    Prof. Tomáš ZIMA, MD, DSc (1966) graduated from the 1st Faculty of Medicine, Charles University, Prague in 1990 and has been Professor of Medical Chemistry and Biochemistry since 2001 and Head of Institute of Medical Biochemistry and Laboratory Medicine since 1999. He has been the Dean of the First Faculty of Medicine, Charles University since 2005. His main research interests include oxidative stress, AGEs, experimental nephrology, tumor markers, and laboratory management and accreditation. He is the author of more than 300 articles and five books, has co-authored 56 chapters in books. He is the Editor in Chief – Folia Biologica and Addictology. Prof. Zima is a member of many learned societies and is on many of their Boards (e.g., he is a member of Executive Board EFCC, and is President of the Czech Society of Clinical Biochemistry). He has received many awards including the “Professor Honoris Causa”, from the Ternopil State Medical University Ivan Horbachevsky, Ternopil, Ukraine and the ESBRA Peter Berner Award (2011).

Published/Copyright: March 24, 2012

Received: 2011-09-11
Accepted: 2012-02-08
Published Online: 2012-03-24
Published in Print: 2012-07-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
  5. Reviews
  6. European medical laboratory accreditation. Present situation and steps to harmonisation
  7. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
  8. Translating exome sequencing from research to clinical diagnostics
  9. Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
  10. Pregnancy-associated plasma protein A: spotlight on kidney diseases
  11. Measurement of factor XIII activity in plasma
  12. Update on multiple sclerosis, its diagnosis and treatments
  13. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
  14. Mini Reviews
  15. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
  16. Highlights in inflammatory bowel disease – from bench to bedside
  17. Opinion Papers
  18. Implementation of standardization in clinical practice: not always an easy task
  19. IFCC standardised HbA1c: should the world be as one?
  20. Reflective testing: adding value to laboratory testing
  21. Original Articles
  22. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  23. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
  24. Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
  25. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0640/html
Scroll to top button